These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
157 related articles for article (PubMed ID: 8098351)
1. [Countermeasure for severe acute cardiomyopathies]. Nakano T; Yamakado T Nihon Naika Gakkai Zasshi; 1993 Feb; 82(2):235-9. PubMed ID: 8098351 [No Abstract] [Full Text] [Related]
2. [Maintenance therapy and various tests during follow-up of cardiomyopathies]. Ogasawara S; Kimata S Nihon Naika Gakkai Zasshi; 1993 Feb; 82(2):231-4. PubMed ID: 8098350 [No Abstract] [Full Text] [Related]
3. [Therapy of hypertrophic cardiomyopathy]. Cecchi F; Olivotto I G Ital Cardiol; 1999 Oct; 29(10):1199-203. PubMed ID: 10546134 [No Abstract] [Full Text] [Related]
4. [Prognosis of hypertrophic and dilated cardiomyopathy]. Ikeda H; Imaizumi T Nihon Rinsho; 2000 Jan; 58(1):86-92. PubMed ID: 10885294 [TBL] [Abstract][Full Text] [Related]
5. [Medical treatment for cardiomyopathies]. Suwa M Nihon Rinsho; 2000 Jan; 58(1):59-63. PubMed ID: 10885289 [TBL] [Abstract][Full Text] [Related]
6. [Treatment of cardiomyopathies from a pathophysiological viewpoint]. Inoo T; Yokota Y Nihon Naika Gakkai Zasshi; 1993 Feb; 82(2):226-30. PubMed ID: 8098349 [No Abstract] [Full Text] [Related]
7. [Heart failure associated with hypertrophic cardiomyopathy]. Oka N; Ohmura H; Ueda T Nihon Rinsho; 2007 May; 65 Suppl 5():425-9. PubMed ID: 17569322 [No Abstract] [Full Text] [Related]
8. [Heart failure due to dilated cardiomyopathy]. Hiramitsu S; Miyagishima K; Mori K; Kimura H Nihon Rinsho; 2007 May; 65 Suppl 5():421-4. PubMed ID: 17569321 [No Abstract] [Full Text] [Related]
9. Effect of the addition of a beta-blocker on left ventricular remodeling and prognosis in patients with dilated cardiomyopathy treated with angiotensin-converting enzyme inhibitor. Hamada M; Hara Y; Ohtsuka T; Suzuki J; Saeki H; Ogimoto A; Shigematsu Y J Cardiovasc Pharmacol; 2003 Jan; 41 Suppl 1():S5-10. PubMed ID: 12688389 [TBL] [Abstract][Full Text] [Related]
10. Medical and surgical therapy of hypertrophic cardiomyopathy. Bonow RO; Maron BJ; Leon MB; Cannon RO; Epstein SE Cardiovasc Clin; 1988; 19(1):221-39. PubMed ID: 2901911 [No Abstract] [Full Text] [Related]
11. [Drug therapy of dilated cardiomyopathy]. Guazzi MD; Alimento M; Mundo E; Viecca M Cardiologia; 1985 Oct; 30(10):909-12. PubMed ID: 2878720 [No Abstract] [Full Text] [Related]
12. [Calcium antagonists in cardiomyopathy]. Takabatake Y Nihon Rinsho; 1991 Jan; 49(1):168-75. PubMed ID: 2002597 [No Abstract] [Full Text] [Related]
13. Pediatric myocardial disease. Towbin JA Pediatr Clin North Am; 1999 Apr; 46(2):289-312, ix. PubMed ID: 10218076 [TBL] [Abstract][Full Text] [Related]
15. [Hypertrophic cardiomyopathy: which therapy? Comparison between beta blockers and calcium antagonists on the symptomatology and natural history of the disease]. Schiavoni G; Favuzzi A; Manzoli U Cardiologia; 1985 Apr; 30(4):265-9. PubMed ID: 2870803 [No Abstract] [Full Text] [Related]
16. Are Angiotensin-converting enzyme inhibitors and beta-blockers ineffective in children with dilated cardiomyopathy and heart failure? Singh TP; Almond C J Am Coll Cardiol; 2010 Aug; 56(10):823; author reply 823-4. PubMed ID: 20797500 [No Abstract] [Full Text] [Related]
17. Cardiomyopathies in adolescents: dilated, hypertrophic, and restrictive. Shaddy RE Adolesc Med; 2001 Feb; 12(1):35-45. PubMed ID: 11224021 [TBL] [Abstract][Full Text] [Related]
19. Understanding the pathophysiology is the key to novel therapies for canine dilated cardiomyopathy. Elliott J; Marr CM Vet J; 2001 Nov; 162(3):168-9. PubMed ID: 11681866 [No Abstract] [Full Text] [Related]
20. New concepts in hypertrophic cardiomyopathies, part II. Roberts R; Sigwart U Circulation; 2001 Oct; 104(18):2249-52. PubMed ID: 11684639 [No Abstract] [Full Text] [Related] [Next] [New Search]